Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation
Authors:
- 17 May 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (11) , 5361-5379
Abstract
G protein coupled receptor 119 (GPR119) is viewed as an attractive target for the treatment of type 2 diabetes and other elements of the metabolic syndrome. During a program toward discovering agonists of GPR119, we herein describe optimization of an initial lead compound, 2, into a development candidate, 42. A key challenge in this program of work was the insolubility of the lead compound. Small-molecule crystallography was utilized to understand the intermolecular interactions in the solid state and resulted in a switch from an aryl sulphone to a 3-cyanopyridyl motif. The compound was shown to be effective in wild-type but not knockout animals, confirming that the biological effects were due to GPR119 agonism.Keywords
This publication has 43 references indexed in Scilit:
- Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profileBioorganic & Medicinal Chemistry Letters, 2012
- Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose controlBioorganic & Medicinal Chemistry Letters, 2011
- 2,5-Disubstituted pyridines as potent GPR119 agonistsBioorganic & Medicinal Chemistry Letters, 2010
- N-Oleoyldopamine Enhances Glucose Homeostasis through the Activation of GPR119Molecular Endocrinology, 2010
- Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119Journal of Medicinal Chemistry, 2008
- GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesityExpert Opinion on Drug Discovery, 2008
- A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide ReleaseEndocrinology, 2008
- A Role for β-Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin ReleaseEndocrinology, 2007
- Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agentsCell Metabolism, 2006
- Seven evolutionarily conserved human rhodopsin G protein‐coupled receptors lacking close relativesFEBS Letters, 2003